Shanghai Kohope Medical Devices Co., Ltd., a leading syringe manufacturer and medical needle manufacturer, today announced a major expansion of its manufacturing operations with a 20% increase in ...

DUBLIN--(BUSINESS WIRE)--Q3 Medical Devices Limited (“Q3 Medical”) based in Dublin, Ireland, announced today that it has entered into a distribution agreement with Medtronic plc for ARCHIMEDES, the ...

The global medical and healthcare products company's $32 million investment in Aurora, IL is expected to create 110 new jobs. State and local officials recently joined Amsino Medical Group to cut the ...

A Minnesota startup that distributes medical devices and develops healthcare inventory management solutions could raise up to half a million dollars for a beta launch in January. CorCardia Group Inc., ...

TORONTO, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, ...

Multinational medical device companies have a long history of driving growth through patented products, strong brands, and direct sales force in the United States and Europe. In China, however, ...

R.R. Donnelley & Sons Company (RRD), a leading global provider of marketing, packaging, print, and supply chain solutions, announced a new solution designed to streamline the product recall ...

CAESAREA, Israel, July 17, 2023 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) (TASE: ICCM) ("IceCure" or the "Company"), developer of minimally-invasive cryoablation technology, the ProSense® ...

PROVIDENCE, R.I.--(BUSINESS WIRE)-- Maternova Inc., empowering global health through innovative solutions, today announced that they have signed an agreement with BirthTech Lda, Portugal, to ...

WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical”, the “Company” or “we”), a supplier of medical devices in ...

Profound Medical shares rose after the company said it has regained distribution rights for its medical device system used to destroy prostate cancer tissue previous licensed out. Shares traded 9.1% ...